Effect of Nanoparticles on Protein Folding and Fibrillogenesis

The large surface area and small size of nanoparticles provide properties and applications that are distinct from those of bulk materials. The ability of nanoparticles to influence protein folding and aggregation is interesting, not only because of the potential beneficial applications, but also the potential risks to human health and the environment. This makes it essential that we understand the effect of nanoparticles on fundamental biological process, like protein folding. Here, we review studies that have examined the effect of nanoparticles on protein folding and aggregation, providing insight both into the mechanisms of these processes and how they may be controlled.

[1]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[2]  V. Rotello,et al.  Synthetic "chaperones": nanoparticle-mediated refolding of thermally denatured proteins. , 2008, Chemical communications.

[3]  G. Narsimhan,et al.  Characterization of secondary and tertiary conformational changes of beta-lactoglobulin adsorbed on silica nanoparticle surfaces. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[4]  Jason C. Young,et al.  Pathways of chaperone-mediated protein folding in the cytosol , 2004, Nature Reviews Molecular Cell Biology.

[5]  I. Rubinstein,et al.  PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro. , 2006, Peptides.

[6]  B. Liedberg,et al.  Folding induced assembly of polypeptide decorated gold nanoparticles. , 2008, Journal of the American Chemical Society.

[7]  Ganesan Narsimhan,et al.  Effect of surface concentration on secondary and tertiary conformational changes of lysozyme adsorbed on silica nanoparticles. , 2008, Biochimica et biophysica acta.

[8]  W. Chan,et al.  Nanotoxicity: the growing need for in vivo study. , 2007, Current opinion in biotechnology.

[9]  N. Hooper,et al.  Emerging and potential therapies for Alzheimer's disease. , 2008, Expert opinion on therapeutic targets.

[10]  I. Rubinstein,et al.  PEGylated phospholipid nanomicelles interact with β-amyloid(1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro , 2006, Peptides.

[11]  N. Yamaguchi,et al.  Protein refolding assisted by self‐assembled nanogels as novel artificial molecular chaperone , 2003, FEBS letters.

[12]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[13]  Kristen M Kulinowski,et al.  Nanoparticles as catalysts for protein fibrillation , 2007, Proceedings of the National Academy of Sciences.

[14]  S. Pal,et al.  Direct conjugation of semiconductor nanocrystals to a globular protein to study protein-folding intermediates. , 2007, The journal of physical chemistry. B.

[15]  Shaojun Dong,et al.  pH-dependent protein conformational changes in albumin:gold nanoparticle bioconjugates: a spectroscopic study. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[16]  Sara Linse,et al.  Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. , 2008, Journal of the American Chemical Society.

[17]  Minyung Lee,et al.  Fullerene inhibits beta-amyloid peptide aggregation. , 2003, Biochemical and biophysical research communications.

[18]  Minyung Lee,et al.  Fullerene inhibits β-amyloid peptide aggregation , 2003 .

[19]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[20]  S. Walter.  Structure and function of the GroE chaperone , 2002, Cellular and Molecular Life Sciences CMLS.

[21]  S. Radford,et al.  Nucleation of protein fibrillation by nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[22]  M. Morris,et al.  Peptide-based nanoparticle for ex vivo and in vivo drug delivery. , 2008, Current pharmaceutical design.

[23]  J. Dordick,et al.  Unfolding of ribonuclease A on silica nanoparticle surfaces. , 2007, Nano letters.

[24]  K. Akiyoshi,et al.  Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: thermal stabilization with refolding of carbonic anhydrase B. , 1999, Bioconjugate chemistry.

[25]  K. Akiyoshi,et al.  Inhibition of the formation of amyloid β‐protein fibrils using biocompatible nanogels as artificial chaperones , 2006, FEBS letters.

[26]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[27]  D. Otzen,et al.  Dendrimer effects on peptide and protein fibrillation. , 2007, Macromolecular bioscience.

[28]  Vikrant Saluja,et al.  Brain permeable nanoparticles. , 2008, Recent patents on CNS drug discovery.

[29]  Lei Zhao,et al.  TiO2 nanoparticles promote beta-amyloid fibrillation in vitro. , 2008, Biochemical and biophysical research communications.

[30]  Robert C. Triulzi,et al.  Photothermal ablation of amyloid aggregates by gold nanoparticles. , 2008, Colloids and surfaces. B, Biointerfaces.

[31]  G. Merlini,et al.  The workings of the amyloid diseases , 2007, Annals of medicine.

[32]  Yu Zhang,et al.  Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. , 2007, Nature nanotechnology.

[33]  Nelson Durán,et al.  New aspects of nanopharmaceutical delivery systems. , 2008, Journal of nanoscience and nanotechnology.

[34]  M. Coelho,et al.  Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. , 2008, Biophysical chemistry.

[35]  Jonathan S Dordick,et al.  Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[36]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[37]  U. Rinas,et al.  Roles of heat-shock chaperones in the production of recombinant proteins in Escherichia coli. , 2004, Advances in biochemical engineering/biotechnology.

[38]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[39]  J. Dobson,et al.  Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.